CYP2D6 Genotypes and Breast Cancer Clinical Outcomes in the Indonesian Population
Clinical trial NCT05501158 · UNKNOWN
Trial details
- NCT number
- NCT05501158
- Sponsor
- Nalagenetics Pte Ltd
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2021-01-01
- Primary completion
- 2024-04-30
- Enrollment
- 150
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.